Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

LI Yan, ZHENG Lingli, YUAN Mingyong, HUANG Ling, JIANG Ting. Discussion on evaluation method of anti-infective therapy by clinical pharmacist[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(1): 70-72. doi: 10.3969/j.issn.1006-0111.2017.01.017
Citation: LI Yan, ZHENG Lingli, YUAN Mingyong, HUANG Ling, JIANG Ting. Discussion on evaluation method of anti-infective therapy by clinical pharmacist[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(1): 70-72. doi: 10.3969/j.issn.1006-0111.2017.01.017

Discussion on evaluation method of anti-infective therapy by clinical pharmacist

doi: 10.3969/j.issn.1006-0111.2017.01.017
  • Received Date: 2015-11-19
  • Rev Recd Date: 2016-05-21
  • Objective To discuss the evaluation method of anti-infective therapy by clinical pharmacist. Methods Anti-infection therapy for an AECOPD patient in department of respiration in our hospital was analyzed to discuss the evaluation method of anti- infective therapy. Results The patient had indication to use antibacterial, and combination of Amikacin and Piperacillin-sulbactam were selected as initial empirical treatment for common respiratory G--bacilli including drug resistant of Pseudomonas aeruginosa, which was rationality. But the whole process of using the initial combination linked to the hospital was unreasonable. Conclusion To evaluate the rationality of anti-infection treatment, the indication to use antibacterial need to be determined firstly, and combined with the severity of the patient, prior treatment, etiology of the site of infection, and choice of antibiotics to evaluate the rationality of initial empiric regimen secondly. For etiology positive results, the efficacy of initial empiric therapy, interpretation of etiology results and the clinical significance, guidelines recommend should be combined, following-up selection of drug to evaluate the rationality of follow-up treatment.
  • [1] 慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组.慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2014年修订版)[J].国际呼吸杂志, 2014,1(34):1-10.
    [2] 中华医学会呼吸病学分会慢阻肺学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中华结核和呼吸杂志, 2013,36(4):1-10.
    [3] 中华医学会呼吸病学分会感染学组.铜绿假单胞菌下呼吸道感染诊治专家共识[J].中华结核和呼吸杂志, 2014,31(7):9-15.
    [4] 胡必杰,王金良.下呼吸道感染实验诊断规范[M].上海:上海科学技术出版社,2006:22-23.
    [5] 孙敬,陈会,余理智,等.痰液培养定植菌与病原菌判断方法的探讨[J].江西医学检验, 2006,24(6):485-488.
    [6] 产超广谱β-内酰胺酶细菌感染防治专家委员会. 产超广谱β-内酰胺酶细菌感染防治专家共识[J].中华实验和临床感染病杂志,2010,4(2):207-214.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(3775) PDF downloads(618) Cited by()

Related
Proportional views

Discussion on evaluation method of anti-infective therapy by clinical pharmacist

doi: 10.3969/j.issn.1006-0111.2017.01.017

Abstract: Objective To discuss the evaluation method of anti-infective therapy by clinical pharmacist. Methods Anti-infection therapy for an AECOPD patient in department of respiration in our hospital was analyzed to discuss the evaluation method of anti- infective therapy. Results The patient had indication to use antibacterial, and combination of Amikacin and Piperacillin-sulbactam were selected as initial empirical treatment for common respiratory G--bacilli including drug resistant of Pseudomonas aeruginosa, which was rationality. But the whole process of using the initial combination linked to the hospital was unreasonable. Conclusion To evaluate the rationality of anti-infection treatment, the indication to use antibacterial need to be determined firstly, and combined with the severity of the patient, prior treatment, etiology of the site of infection, and choice of antibiotics to evaluate the rationality of initial empiric regimen secondly. For etiology positive results, the efficacy of initial empiric therapy, interpretation of etiology results and the clinical significance, guidelines recommend should be combined, following-up selection of drug to evaluate the rationality of follow-up treatment.

LI Yan, ZHENG Lingli, YUAN Mingyong, HUANG Ling, JIANG Ting. Discussion on evaluation method of anti-infective therapy by clinical pharmacist[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(1): 70-72. doi: 10.3969/j.issn.1006-0111.2017.01.017
Citation: LI Yan, ZHENG Lingli, YUAN Mingyong, HUANG Ling, JIANG Ting. Discussion on evaluation method of anti-infective therapy by clinical pharmacist[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(1): 70-72. doi: 10.3969/j.issn.1006-0111.2017.01.017
Reference (6)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return